1-deoxynojirimycin has been researched along with Fasting Hypoglycemia in 13 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (7.69) | 18.7374 |
| 1990's | 3 (23.08) | 18.2507 |
| 2000's | 2 (15.38) | 29.6817 |
| 2010's | 6 (46.15) | 24.3611 |
| 2020's | 1 (7.69) | 2.80 |
| Authors | Studies |
|---|---|
| Donovan, CM; Jokiaho, AJ; Winchester, M | 1 |
| Hanaoka, H; Hashimoto, N; Ishikawa, K; Kanatsuka, A; Kobayashi, K; Kuribayashi, N; Onishi, S; Sakurai, K; Sato, Y; Takemoto, M; Terano, T; Uchida, D; Yokoh, H; Yokote, K | 1 |
| Murohashi, Y; Okazaki, N; Okuyama, T; Shirakawa, J; Tamura, T; Terauchi, Y; Togashi, Y; Yamazaki, S | 1 |
| Hirose, S; Iwahashi, Y; Seo, A; Sumiyoshi, M; Takahashi, T; Tamori, Y | 1 |
| Hosoba, M; Kakei, M; Nanjo, H; Narita, T; Sato, T; Satoh, K; Uchinami, H; Yamada, Y; Yamamoto, Y | 1 |
| Hamaguchi, T; Katsuno, T; Konishi, K; Kusunoki, Y; Miuchi, M; Miyagawa, J; Murai, K; Nagai, E; Namba, M; Ochi, F; Tokuda, M | 1 |
| Fujita, Y; Funahashi, T; Imagawa, A; Iwahashi, H; Kaneto, H; Kitamura, T; Kobayashi, Y; Kozawa, J; Maeda, N; Okita, K; Otsuki, M; Sasaki, S; Shimomura, I; Tamada, D; Yasuda, T | 1 |
| Haslbeck, M; Jakob, S; Kellerer, M; Linn, T | 1 |
| Kasuga, M; Sakaguchi, K | 1 |
| Tattersall, R | 1 |
| Berlin, C; Feig, PU; Petzinna, D; Ratzmann, KP; Rybka, J; Schernthaner, G; Segal, P | 1 |
| Kuritzky, L; Quillen, DM; Samraj, G | 1 |
| Cañizo, JF; Hillebrand, I; Navascués, I; Sabán, J; Serrano-Rios, M | 1 |
4 review(s) available for 1-deoxynojirimycin and Fasting Hypoglycemia
| Article | Year |
|---|---|
[Continuation 50. Type 2 diabetes: possibilities and limitations of pharmacological therapy].
Topics: 1-Deoxynojirimycin; Acarbose; Aged; Blood Glucose; Carbamates; Contraindications; Cyclohexanes; Diabetes Mellitus, Type 2; Drug Therapy, Combination; Enzyme Inhibitors; Fasting; Follow-Up Studies; Germany; Glucosamine; Glyburide; Glycated Hemoglobin; Glycoside Hydrolase Inhibitors; Humans; Hypoglycemia; Hypoglycemic Agents; Imino Pyranoses; Insulin; Metformin; Middle Aged; Nateglinide; Obesity; Patient Compliance; Phenylalanine; Pioglitazone; Piperidines; Practice Guidelines as Topic; Risk Factors; Rosiglitazone; Sulfonylurea Compounds; Thiazolidinediones; Time Factors | 2003 |
[Adverse effects of alpha-glucosidase inhibitors].
Topics: 1-Deoxynojirimycin; Acarbose; Digestive System Diseases; Drug Interactions; Enzyme Inhibitors; Glycoside Hydrolase Inhibitors; Humans; Hyperammonemia; Hypoglycemia; Hypoglycemic Agents; Imino Pyranoses; Inositol | 2007 |
Alpha-glucosidase inhibition as an adjunct to the treatment of type 1 diabetes.
Topics: 1-Deoxynojirimycin; Acarbose; Blood Glucose; Diabetes Mellitus, Type 1; Eating; Glucosamine; Glycoside Hydrolase Inhibitors; Humans; Hyperglycemia; Hypoglycemia; Imino Pyranoses; Trisaccharides | 1993 |
Improving management of type 2 diabetes mellitus: 1. alpha-Glucosidase inhibitors.
Topics: 1-Deoxynojirimycin; Acarbose; Diabetes Mellitus, Type 2; Enzyme Inhibitors; Glucosamine; Glycoside Hydrolase Inhibitors; Humans; Hypoglycemia; Imino Pyranoses | 1999 |
4 trial(s) available for 1-deoxynojirimycin and Fasting Hypoglycemia
| Article | Year |
|---|---|
Efficacy and safety of the dipeptidyl peptidase-4 inhibitor sitagliptin compared with α-glucosidase inhibitor in Japanese patients with type 2 diabetes inadequately controlled on sulfonylurea alone (SUCCESS-2): a multicenter, randomized, open-label, non-i
Topics: 1-Deoxynojirimycin; Aged; alpha-Glucosidases; Diabetes Mellitus, Type 2; Dipeptidyl-Peptidase IV Inhibitors; Drug Therapy, Combination; Female; Gastrointestinal Agents; Glycated Hemoglobin; Glycoside Hydrolase Inhibitors; Humans; Hyperglycemia; Hypoglycemia; Hypoglycemic Agents; Inositol; Japan; Male; Middle Aged; Pyrazines; Sitagliptin Phosphate; Sulfonylurea Compounds; Triazoles | 2014 |
Effects of miglitol in combination with intensive insulin therapy on blood glucose control with special reference to incretin responses in type 1 diabetes mellitus.
Topics: 1-Deoxynojirimycin; Adult; Aged; Deoxyglucose; Diabetes Mellitus, Type 1; Drug Therapy, Combination; Enzyme Inhibitors; Gastric Inhibitory Polypeptide; Glucagon-Like Peptide 1; Glycated Hemoglobin; Glycated Serum Albumin; Glycation End Products, Advanced; Glycoside Hydrolase Inhibitors; Humans; Hyperglycemia; Hypoglycemia; Hypoglycemic Agents; Incretins; Insulin; Male; Middle Aged; Serum Albumin; Weight Loss; Young Adult | 2011 |
The efficacy and safety of miglitol therapy compared with glibenclamide in patients with NIDDM inadequately controlled by diet alone.
Topics: 1-Deoxynojirimycin; Adult; Aged; Blood Glucose; Diabetes Mellitus, Type 2; Diarrhea; Diet, Diabetic; Double-Blind Method; Enzyme Inhibitors; Fasting; Female; Flatulence; Glucosamine; Glyburide; Glycated Hemoglobin; Glycoside Hydrolase Inhibitors; Humans; Hypoglycemia; Hypoglycemic Agents; Imino Pyranoses; Male; Middle Aged; Placebos; Postprandial Period | 1997 |
Effect of two new alpha-glucosidase inhibitors in insulin-dependent diabetic patients.
Topics: 1-Deoxynojirimycin; Adult; Diabetes Mellitus, Type 1; Diet; Double-Blind Method; Female; Glucosamine; Glucosidases; Humans; Hyperglycemia; Hypoglycemia; Imino Pyranoses; Insulin; Male; Random Allocation | 1988 |
5 other study(ies) available for 1-deoxynojirimycin and Fasting Hypoglycemia
| Article | Year |
|---|---|
N-Hydroxyethyl-1-Deoxynojirimycin (Miglitol) Restores the Counterregulatory Response to Hypoglycemia Following Antecedent Hypoglycemia.
Topics: 1-Deoxynojirimycin; Animals; Blood Glucose; Diabetes Mellitus, Type 2; Epinephrine; Glucose Clamp Technique; Hypoglycemia; Hypoglycemic Agents; Insulin; Norepinephrine; Rats; Sodium | 2022 |
Using miglitol at 30 min before meal is effective in hyperinsulinemic hypoglycemia after a total gastrectomy.
Topics: 1-Deoxynojirimycin; Blood Glucose; Drug Administration Schedule; Female; Gastrectomy; Humans; Hypoglycemia; Hypoglycemic Agents; Insulin; Meals; Middle Aged; Postprandial Period | 2014 |
Concurrent Therapy with a Low-carbohydrate Diet and Miglitol Remarkably Improved the Postprandial Blood Glucose and Insulin Levels in a Patient with Reactive Hypoglycemia due to Late Dumping Syndrome.
Topics: 1-Deoxynojirimycin; Aged; Blood Glucose; Combined Modality Therapy; Diet, Carbohydrate-Restricted; Dumping Syndrome; Glucose Tolerance Test; Glycoside Hydrolase Inhibitors; Humans; Hypoglycemia; Hypoglycemic Agents; Insulin; Male; Postprandial Period | 2016 |
A case of insulinoma following total gastrectomy--effects of an alpha-glucosidase inhibitor on suppressing GIP and GLP-1 elevations.
Topics: 1-Deoxynojirimycin; Female; Gastrectomy; Gastric Inhibitory Polypeptide; Glucagon-Like Peptide 1; Glycoside Hydrolase Inhibitors; Humans; Hypoglycemia; Insulinoma; Middle Aged; Pancreatic Neoplasms; Postprandial Period | 2010 |
Successful treatment of reactive hypoglycemia secondary to late dumping syndrome using miglitol.
Topics: 1-Deoxynojirimycin; Dose-Response Relationship, Drug; Dumping Syndrome; Enzyme Inhibitors; Female; Glycoside Hydrolase Inhibitors; Humans; Hypoglycemia; Middle Aged; Treatment Outcome | 2012 |